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Abstract
Aims
Dilated cardiomyopathy (DCM), a myocardial disorder that can result in progressive heart fail-
ure and arrhythmias, is defined by ventricular chamber enlargement and dilatation, and systolic
dysfunction. Despite extensive research, the pathological mechanisms of DCM are unclear
mainly due to numerous mutations in different gene families resulting in the same outcome—
decreased ventricular function. Titin (TTN)—a giant protein, expressed in cardiac and skeletal
muscles, is an important part of the sarcomere, and thus TTN mutations are the most common
cause of adult DCM. To decipher the basis for the cardiac pathology in titin-mutated patients,
we investigated the hypothesis that induced Pluripotent Stem Cell (iPSC)-derived cardiomyo-
cytes (iPSC-CM) generated from patients, recapitulate the disease phenotype. The hypothesis
was tested by 3 Aims: (1) Investigate key features of the excitation-contraction-coupling
machinery; (2) Investigate the responsiveness to positive inotropic interventions; (3) Investigate
the proteome profile of the AuP cardiomyocytes using mass-spectrometry (MS).
Methods and results
iPSC were generated from the patients’ skin fibroblasts. The major findings were: (1) Sarco-
meric organization analysis in mutated iPSC-CM showed defects in assembly and
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maintenance of sarcomeric structure. (2) Mutated iPSC-CM exhibited diminished inotropic
and lusitropic responses to β-adrenergic stimulation with isoproterenol, increased [Ca2+]out
and angiotensin-II. Additionally, mutated iPSC-CM displayed prolonged recovery in response
to caffeine. These findings may result from defective or lack of interactions of the sarcomeric
components with titin through its kinase domain which is absent in the mutated cells.
Conclusions
These findings show that the mutated cardiomyocytes from DCM patients recapitulate
abnormalities of the inherited cardiomyopathies, expressed as blunted inotropic response.
Introduction
Dilated cardiomyopathy (DCM), the most common cardiomyopathy, is a myocardial disorder
defined by ventricular chamber enlargement and dilatation, and systolic dysfunction that can
result in progressive heart failure, supraventricular and ventricular arrhythmias. Consequently,
DCM is a major cause of morbidity and mortality contributing significantly to health care costs
[1–3]. The prevalence and incidence of idiopathic DCM were estimated to be 1:2500 individuals
and 6–7:100,000 respectively, but the data collected was based on outdated diagnosis methods.
In 20–50% of cases the disease is inherited and is referred as familial DCM [2,3]. The most com-
mon inheritance form of DCM is autosomal dominant transmission, although other forms
were described, such as autosomal recessive, X-linked and mitochondrial inheritance [4].
Despite extensive research in recent years, the complex pathological mechanisms of DCM
are still unclear, mainly because numerous mutations in different gene families result in a simi-
lar outcome—depressed ventricular function. Hence, mutations in nuclear, sarcomeric, cyto-
skeletal and surface membrane, impair myocardial force generation and relaxation, force
transmission, and/or cell survival. Furthermore, even when a mutation is identified, the link
between the genetic abnormality and cardiac dysfunction is often unclear [5].
Titin, the largest sarcomeric protein, is expressed in cardiac and skeletal muscles and is
encoded by the TTN gene. The titin protein is located within the sarcomere as a third filament
around 1 μm in length connecting between Z-line and M-line [2,3]. Titin functions as a molec-
ular bi-directional spring responsible for the passive elasticity of the muscle, by creating a
restoring force that causes the sarcomere to return to its resting length [6,7]. Mutations in titin
are a frequent cause of DCM [8], and were described in several families inherited as an autoso-
mal dominant trait.
To decipher the cellular basis for the cardiac pathology in titin-mutated patients, we investi-
gated the hypothesis that iPSC-CM generated from titin-mutated DCM patients recapitulate
key aspects of the disease phenotype. To this end, we generated iPSC-CM from two DCM
patients [9,10] carrying different mutations in the TTN gene, and investigated their excitation-
contraction coupling (ECC) machinery and responsiveness to common positive inotropic
interventions. The present study demonstrates that while the basal ECC machinery of titin-
mutated iPSC-CM appears intact, their responsiveness to positive inotropic interventions is
blunted compared to healthy iPSC-CM.
Methods
http://dx.doi.org/10.17504/protocols.io.tvien4e
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Generation of patient-specific induced pluripotent stem cells
Skin biopsies were acquired according to approval #3611 issued by the Helsinki Committee
for experiments on human subjects at the Rambam Health Care Campus, Haifa, Israel. The
biopsy [human dermal fibroblasts (HDF)] was obtained from a 28-year-old DCM patient
(denoted IsP) from an Israeli family carrying an adenine insertion mutation, causing a frame
shift and resulting in a stop codon and protein truncation after 19,628 amino acids [9]. Addi-
tional skin (HDF24) and hair (KTN3 and KTI [11,12]) biopsies were obtained from healthy
subjects as control. The dermal fibroblasts generated from the skin biopsies were repro-
grammed as previously described [13] using the STEMCCA Cassette (a single lentiviral vector
containing the four factors: Oct4, Sox2, Klf4 and c-Myc) and induced Pluripotent Stem Cells
(iPSC) were generated (IsP DCM clones 23.2 and 23.10). These iPSC clones were spontane-
ously differentiated into functional cardiomyocytes as previously described [11–13].
Karyotype analysis
Karyotype analysis was performed using standard G-banding chromosome analysis by the
cytogenetic laboratory according to standard procedures.
Teratoma formation
To evaluate the iPSC differentiation capacity in vivo, 5-day-old iPSC colonies from one 6-well
plate were detached using 1 mg/ml type IV collagenase, washed 3 times in PBS and then
injected into thigh muscle of severe combined immunodeficient (SCID) mice. Teratomas were
observed 8–12 weeks after injection, and images were obtained from formalin-fixed (4%) and
paraffin-embedded teratoma sections stained with hematoxylin and eosin (H&E) [14–16].
Genotyping
To confirm that the mutation is preserved in the iPSC clones, sequence analysis was performed
on the titin gene both in the patients-derived iPSC and fibroblasts by performing PCR using
primers which delimit the mutation area in the mutated gene. The PCR was performed on
genomic DNA produced from the patients’ fibroblasts and iPSC using Promega DNA purifica-
tion kit, with the primers: F-5’-TATTGCCTGGGTTAAGCCGC-3’ and R-5’-AGCTCCTG
TTGTTAGTCCGC-3’.
Immunofluorescence staining
Immunofluorescence staining was performed according to standard protocols using the fol-
lowing antibodies: Alexa Fluor 555 donkey anti-rabbit (1:100; Life Technologies, Eugene, OR,
USA), Alexa Fluor 488 donkey anti mouse (1:100; Life Technologies, Eugene, OR, USA), cy5
donkey anti goat (1:100; Invitrogene, Eugene, Oregon, USA), OCT3/4 (1:100; Millipore, Santa
Cruz, CA, USA), SSEA4 (1:100; Millipore, Temecula, CA, USA), TRA1-60 (1:100; Millipore,
Temecula, CA, California), Nanog (1:50; R&D, Minneapolis, MN, USA), DAPI (1:500; Sigma
Aldrich, St. Louis, MO, USA).
Action potential recordings
For action potentials (AP) recordings, spontaneously contracting areas of EBs (control data
was obtained from experiments on KTI and KTN3 clones used in Ben-Ari et al [11]) were
mechanically and/or enzymatically dispersed (collagenase II 1 mg/ml; Worthington, Lake-
wood, New Jersey, USA, http://www.worthington-biochem.com). Small clusters were then
plated on gelatin-coated glass coverslips (13 mm diameter) in 24-well plates. The coverslips
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were incubated at 37˚C, and a recovery period of at least two days was allowed before the
electrophysiological experiment was performed [11]. In all experiments, the coverslips were
perfused at 37˚C with an external solution containing (in mM): 140 NaCl, 5.4 KCl, 1.8 CaCl2,
1 MgCl2, 10 glucose and 10 HEPES titrated to pH 7.4 with NaOH. The patch pipette solution
contained (mM): 120 KCl, 1 MgCl2, 3 Mg-ATP, 10 HEPES, and 10 EGTA titrated to pH 7.2
with KOH and adjusted at 290 mOsm with saccharose (all materials were purchased from
Sigma-Aldrich). Axopatch 200B, Digidata 1322 and pClamp10 (Molecular Devices, Sunnyvale,
CA) were used for data amplification, acquisition and analysis. Signals were digitized at 10
kHz and filtered at 2 kHz. Microelectrodes with resistances of 4–7 MΩ were pulled from boro-
silicate glass capillaries (Harvard Apparatus, Holliston, USA). Analysis was preformed using
MATLAB software (MathWorks, Natick, MA, USA). Corrected AP duration (APD) was calcu-
lated by the Bazett’s correction (cAPD ¼ APDffiffiffiffiffiffiffiffiffi
60
beat rate
p ).
Extracellular electrograms recorded from spontaneously contracting EBs
and analysis of Beat Rate Variability (BRV)
Extracellular electrograms were recorded from spontaneously contracting 30–60 day-old EBs
using the Micro-Electrode-Array (MEA) apparatus (Multi Channels Systems, Reutlingen, Ger-
many) routinely used in our lab [11,17]. The MEA set-up consists of a 50×50-mm glass sub-
strate, in the center of which is embedded a 1.4×1.4 mm matrix of 60 titanium-nitride
electrodes. The electrode diameter is 30 µm and inter-electrode distance is 200 µm. Spontane-
ously contracting EBs were mechanically dissected and adhered onto the MEA dish and their
electrical activity was recorded by the MEA data acquisition software at sampling rate of 1000
Hz which was down-sampled to 200 Hz. During the recording, the cultures were kept in a
bath-like conformation of a glass cylinder (glued to the center of the MEA plane) filled with
500 µL of culture medium saturated with a gas mixture consisting of 5% CO2 + 95% air. The
temperature was kept at 37˚C using a heating element and a temperature controller.
For BRV analysis, all recordings were analyzed to detect peaks of the activation spikes, from
which inter-beat intervals (denoted ‘IBI’) were calculated using MATLAB software (Math-
Works, Natick, MA, USA). To generate Poincare´ plots, each R-R interval (IBIn+1) is plotted
against its predecessor (IBIn), creating a scattered mass of points in a two-dimensional array.
Quantitative analysis of the plot is performed by fitting an ellipse to the group of points, with
its center coinciding with the centroid of the ellipse (the point of the average IBI), and adjust-
ing two perpendicular lines traversing the centroid. The longitudinal line designated SD2, rep-
resents long-term variability of the data (reflecting the standard deviation of the IBIs. The
perpendicular line designated SD1 represents short-term beat-to-beat variability [18].
Measurements of intracellular Ca2+ transients and contractions
Intracellular Ca2+ ([Ca2+]i) transients and contractions were recorded from small contracting
40-70-day old embryoid bodies (EBs) by means of fura-2 fluorescence and video edge detector,
respectively, using the IonOptix Calcium and Contractility system (Westwood, MA, USA) as
previously described [19–21]. In brief, spontaneously contracting EBs were mechanically dis-
sected and adhered onto 18 mm diameter gelatin-coated glass slides. Subsequently, fura-
2-stained (2.5 μM) contracting areas were transferred to a chamber mounted on the stage of
an inverted microscope and perfused at a rate of 1–1.5 ml/min Tyrode’s solution at 37˚C.
The Tyrode’s solution contains (mmol/l): 140 NaCl, 5.4 KCl, 1 MgCl2, 2 sodium pyrovate, 1
CaCl2, 10 HEPES, 10 glucose (pH 7.4 adjusted with NaOH). The EBs were paced at 0.5–2.5 Hz
which corresponded to a frequency 20–50% higher than the spontaneous beating rate. The
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acquisition rate of both the [Ca2+]i transients and contractions was 100 points/sec. Analysis
was performed using the IonOptix designated system. To characterize the [Ca2+]i transients
amplitude, the differences between maximal (systolic) and minimal (diastolic) ratio were cal-
culated in 20 successive transients and averaged (RAmp). Similarly, the contraction amplitude
(LAmp) was calculated from the average differences between minimal and maximal video cur-
sor positions of 20 successive contractions. In addition, the maximal rates of [Ca2+]i rise (+d
[Ca2+]i/dt) and decay (-d[Ca
2+]i/dtRelax), and maximal rates of contraction (dL/dtContraction)
and relaxation (dL/dtRelaxation) were calculated and averaged over 20 [Ca
2+]i transients and
contractions, respectively. The data from the Israeli iPSC-derived cardiomyocytes (iPSC-CM)
are pulled from two clones.
Immunocytological analysis in iPSC-CM
iPSC-CM were fixed in 3.7% (vol/vol) formaldehyde and subjected to immunostaining as pre-
viously reported [13]. Sarcomere structure was visualized using primary antibodies against
cardiac troponin T (mouse monoclonal clone 13–11, Lab Vision, 1:500) and α-actinin (mouse
monoclonal clone EA-53, Sigma-Aldrich, 1:300). Alexa-Fluor-488, and -594 conjugated sec-
ondary antibodies specific to the appropriate species were used (Life Technologies, 1:500).
Nuclei were detected with 1 µg/ml Hoechst 33528. Microscopy was performed using imaging
systems (DMI6000-AF6000), filter cubes and software from Leica microsystems. Images were
assigned with pseudo-colors. Morphological analyses were performed by investigators blinded
to the genotype of the cells.
Mass Spectrometry sample preparation and data processing
iPSC-CM were resuspended in a lysis buffer containing 6M guanidinium chloride (GCl), boiled
for 5 minutes and subsequently reduced with 10 mM tris (2-carboxyethyl) phosphine (TCEP)
and alkylated with 40 mM 2-chloro-N,N-diethylacetamide. Samples were diluted (10% acetoni-
trile, 25 mM Tris pH 8.5), first 1:3 Lysate: Buffer for LysC digestion (25˚C 3 hours), then 1:10 for
Trypsin digestion. Samples were incubated at 37˚C overnight under continuous shaking. The
digestion was blocked by acidifying the sample with TFA (1% total). Peptides were de-salted
using SDB-RPS StageTips as described [22]. Mass-spectrometry (MS) analysis was performed in
triplicates using a nanoflow uHPLC system (Easy1000 nLC,) coupled via a nanoelectrospray ion
source to a Q Exactive mass spectrometer (all from Thermo Fisher Scientific). Peptides were
separated on a 50 cm long column with 75 μm inner diameter, packed in-house with ReproSil-
Pur C18-AQ 1.9 μm resin (Dr. Maisch GmbH). Column temperature was kept at 50˚C. Peptide
separation was carried out by loading the peptides in buffer A (0.1% (v/v) formic acid) and elut-
ing them in 120 or 240 minutes with a nonlinear gradient of 5–60% buffer B (0.1% (v/v) formic
acid, 80% (v/v) acetonitrile) at a flow rate of 250 nl/min. MS analysis of peptides was performed
in a data-dependent acquisition mode, with survey scans (300–1700 m/z, maximum ion injec-
tion times 60 ms) acquired at a resolution of 60,000 followed by higher-energy collisional disso-
ciation (HCD) based fragmentation of up to 15 most abundant precursor ions. The MS/MS
scans were acquired at a resolution of 15,000 (maximum ion injection times 60 ms). Repeated
sequencing of peptides was minimized by setting a dynamic exclusion of 20 s.
Raw MS files were processed with MaxQuant (version. 1.6.1.3) [23]. The false discovery
rate (FDR) cut-off was set to 1% for protein and peptide spectrum matches. Peptides were
required to have a minimum length of 7 amino acids and a maximum mass of 4600 Da. Peak
list files were searched against the UniprotKB Homo sapiens database, based on the 2018_02
release, combined with 245 common contaminants by the integrated Andromeda search
engine [24]. The mass spectrometry proteomics data have been deposited to the
Functional abnormalities in iPSC-CMs generated from titin-mutated patients with dilated cardiomyopathy
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ProteomeXchange Consortium via the partner repository with the dataset identifier
PXD010513. Data analysis, statistics and annotation enrichment analysis was performed with
the Perseus software package, version 1.5.4.2 [25]. Protein Groups were filtered for at least two
valid values in at least one group of triplicates. Differentially expressed proteins were identified
by t-test at a permutation-based FDR cut-off of 0.05, 250 randomizations and S0 = 0.5, which
was used to determine the curves of the volcano plot. Pathway enrichment analysis was per-
formed using Fisher exact test with a Benjamini-Hochberg FDR cutoff of 0.02. GOCC, GOBP,
GOMF, CORUM, Uniprot Keywords and KEGG pathway annotations were used for the anal-
ysis. Bar plots were generated of significant protein of interest was performed by differential
enrichment analysis of proteomic data, DEP [26].
Transmission electron microscopy
Transmission electron microscopy (TEM) was performed on 31- and 56-day-old (post-plat-
ing) iPSC-CM from IsP and AuP DCM patients (n = 2 each for two clones) and from healthy
controls (n = 2). The samples were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer,
post fixed in potassium ferrocyanide reduced osmium, and further processed for epoxy resin
(Agar100) embedded as previously reported [27]. The ultra-thin sections were cut with a dia-
mond knife at 60 nm thicknesses using an EM UC7 Leica ultramicrotome (Leica Microsys-
tems, Wetzlar, Germany) and double stained with 1% uranyl acetate and Reynolds lead citrate.
TEM was performed using a Morgagni 286 transmission electron microscope (FEI Company,
Eindhoven, The Netherlands) at 80 kV. Digital electron micrographs were recorded with a
MegaView III CD and iTEM-SIS software (Olympus, Soft Imaging System GmbH, Mu¨nster,
Germany). Digital electron micrographs were recorded with a MegaView III CD. From each
sample, two separate EBs from each batch were examined under electron microscope. Ten
CMs of each EBs were photographed. The measurements were performed to assess the length
of sarcomeres and the size of the Z-bands (sarcomeres width). The measurements were done
using iTEM-SIS software (Figs D and E in S1 File (Olympus, Soft Imaging System GmbH,
Mu¨nster, Germany) and exported as Excel documents.
Statistical analysis
Results are expressed as Mean±SEM and represent mean percentage of change (unless indi-
cated otherwise). Data were analyzed with Sigmastat (Systat Software Inc., Chicago, Illinois)
and Prism 5.0 (GraphPad Software, San Diego, California). P<0.05 was considered significant.
Results
The titin-mutated patients
The Israeli DCM patient (denoted IsP) was a 28-year old (at the time of skin biopsy) affected
male described by Yoskovitz et al [9]. See On-line Supplement for clinical data. The mutation
is an adenine insertion at position 86076 (c.86076dupA) causing a frameshift in the TTN gene.
The Australian DCM patient (denoted AuP) was a 62 year old previously described by Gerull
et al [28]. The mutation is a 2-bp insertion of adenine and thymidine at position 70690
(c.70690dupAT) leading to a frameshift with premature stop codon in the TTN gene. Clinical
data are provided in the On-line Supplement.
iPSC generation, characterization and differentiation into cardiomyocytes
The IsP iPSC clones 23.2 and 23.10 displayed normal karyotype (FigA in S1 File), expressed
the pluripotent markers SSEA4, Oct4, TRA1-60 and Nanog (Panels A and B of FigB in S1 File)
Functional abnormalities in iPSC-CMs generated from titin-mutated patients with dilated cardiomyopathy
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and demonstrated in vivo pluripotency (Panels C and D of FigB in S1 File). As seen in FigC in
S1 File, the adenine insertion is present in the mutated fibroblasts and mutated iPSC clones,
but absent in the healthy iPSC clone. The AuP iPSC and iPSC-CM were previously character-
ized by Gramlich and co-workers [10]. Table B in S1 File provides additional details on the
patients (age, clinical characteristics), the generated iPSC (number of iPSC clones) and cardio-
myocytes obtained and analyzed from each patient.
Automaticity and the excitation-contraction coupling (ECC) machinery
Transmembrane action potential characteristics. Firstly, we analyzed action potential
(AP) characteristics in IsP, AuP and healthy spontaneously firing cardiomyocytes. While AP
amplitude and maximal upstroke velocity of phase 0 depolarization (dV/dtmax) were similar in
IsP, AuP and healthy cardiomyocytes, the spontaneous firing rate was lower (P<0.01) in IsP
iPSC-CM than control. In addition, APD at 50% and 90% repolarization (APD50 and APD90,
respectively) were prolonged in IsP and AuP iPSC-CM compared to healthy iPSC-CM. However,
when corrected to beat rate, the three groups showed no significant difference in APD50, and in
only APD90 of IsP iPSC-CM was slightly (by 39 ms) prolonged compared to control (Fig 1).
Automaticity, chronotropic β-adrenergic responsiveness and Beat Rate Variability
(BRV). In addition to the electrophysiological measurements at the cell level (Fig 1), we
determined at the network level (a contracting EB) the spontaneous beat rate and the
Fig 1. Action potential (AP) characteristics of healthy and mutated (IsP and AuP) iPSC-CM. [A-C] Recordings of spontaneous AP from healthy [A], IsP [B] and
AuP [C] iPSC-CM. [D-J] Spontaneous AP parameters of healthy (38–77 day-old; black), IsP (54–77 day-old; red) and AuP (38–49 day old; blue) iPSC-CM: [D] beat rate,
[E] action potential amplitude (APA), [F] maximum rate of phase 0 depolarization (dV/dtmax), [G] and [I] action potential duration at 50% (APD50) and 90% (APD90)
repolarization, respectively. [H] and [J] Corrected action potential duration at 50% (cAPD50) and 90% (cAPD90) repolarization, respectively. Healthy (clone KTI n = 23,
clone KTN3 n = 30, n = 53); IsP (clone 23.2 n = 9, clone 23.10 n = 3, n = 12); AuP (n = 9). One-way ANOVA (on APA, dV/dtmax, beat rate, APD50 and APD90) was
performed followed by Holm-Sidak test, �P<0.05, ��P<0.01 and ���P<0.001 vs healthy.
https://doi.org/10.1371/journal.pone.0205719.g001
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chronotropic response to β-adrenergic stimulation (Fig 2) as well as BRV characteristics, rep-
resenting the non-linear firing patterns (Fig 3). As seen by representative electrograms (Fig
2A, upper row) and the summary (Fig 2B), the mean beat rate was similar in all 3 groups, sug-
gesting that the titin mutation did not affect the basic mechanisms of automaticity. To deter-
mine whether the titin mutation altered the chronotropic responsiveness to β-adrenergic
stimulation, we analyzed the effects of isoproterenol on the spontaneous beat rate of healthy
(black), IsP (red) and AuP (blue) EBs. As illustrated in Fig 2A (middle row) and 2C, isoproter-
enol had a similar positive chronotropic effect in all 3 experimental groups, which was blocked
by the β-blocker metoprolol (Fig 2A lower row).
As we previously showed that defective intracellular Ca2+ handling augments BRV magni-
tude [11,29], we compared BRV features between mutated and healthy EBs (Fig 3). The IBI
Fig 2. The chronotropic response to isoproterenol on spontaneous beat rate of healthy (black symbols), IsP (red symbols) and AuP (blue symbols) EBs. Panel [A]
shows representative spontaneous electrogram recordings from healthy (left), IsP (middle) and AuP (right) EBs in the absence (upper) and presence (middle) of
isoproterenol. The positive chronotropic effect of isoproterenol is blocked by the β-blocker metoprolol (lower). [B] The spontaneous beating rate of healthy (clone 24.5
n = 6, clone KTN3 n = 5, clone KTI n = 7, n = 18), IsP (clone 23.10 n = 5) and AuP (n = 3) EBs. [C] Summary of the response to isoproterenol of healthy (black), IsP
(red) and AuP (blue) EBs. Results are expressed as Mean±SEM. There is no statistically significant difference between the groups in Two-way ANOVA test. Iso–
isoproterenol, MP–metoprolol.
https://doi.org/10.1371/journal.pone.0205719.g002
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time series (Fig 3B–3E) and IBIs histogram distribution (Fig 3J–3L) show that the IBI range of
AuP EBs (~3000 ms) is broader than healthy (~400 ms) and IsP (~150 ms) EBs. The larger IBI
dispersion of AuP EBs is also demonstrated by the much more scattered Poincare´ plot (Fig
3F–3I). Accordingly, the BRV characteristics: Coefficient of variation (Fig 3M), and Poincare´
plots SD1 (Fig 3N) and SD2 (Fig 3O) were larger in AuP than in healthy and IsP EBs.
[Ca2+]i transient and contraction characteristics. Because titin is a key structural protein
featuring several regulatory domains [7], we investigated whether the [Ca2+]i transient and
contraction characteristics are altered in the mutated cardiomyocytes representative record-
ings from the 3 groups are illustrated in Fig 4A. Except for the following changes, all other
[Ca2+]i transient and contraction characteristics were similar in the 3 groups: (1) The contrac-
tion amplitude of mutated iPSC-CM was lower (�P< 0.05, ��P< 0.01; in IsP and AuP respec-
tively) than in healthy iPSC-CM (Fig 4E). (2) AuP dL/dtRelaxation was lower (
�P< 0.05) than
healthy and IsP iPSC-CM (Fig 4G). (3) IsP maximal rate of [Ca2+]i rise (+d[Ca
2+]i/dt) was
higher (��P< 0.01) than in healthy iPSC-CM (Fig 4C). (4) IsP minimal rate of [Ca2+]i rise (-d
[Ca2+]i/dt) was higher (
�P< 0.05) than in healthy iPSC-CM (Fig 4D).
The responsiveness to positive inotropic interventions
As Gramlich et al demonstrated that exposure of mice with truncated titin to isoproterenol or
angiotensin-II (AT-II) mimic typical features of DCM—left ventricular dilatation with
Fig 3. BRV characterization of EBs generated from healthy, IsP and AuP iPSC. [A] Representative electrogram recording from healthy, IsP and AuP iPSC-CM.
[B-D] Representative IBIs time series of healthy (black), IsP (red) and AuP (blue) iPSC-CM and [E] combined IBIs time series. [F-H] Poincare´ plots and [I] combined
Poincare´ plots of healthy (black), IsP (red) and AuP (blue) iPSC-CM. [J-L] histogram distribution of IBIs. [M-O] Summary of Coefficient of variation (COV) of IBIs (IBI
CV) [M], SD1 [N] and SD2 [O] of Poincare´ plots in healthy (clone 24.5 n = 6, clone KTN3 n = 5, clone KTI n = 6, n = 17), IsP (clone 23.10 n = 5) and AuP (n = 3) EBs.
One-way ANOVA was performed followed by Holm-Sidak test, �P<0.05, ��P<0.01 and ���P<0.001 vs. healthy.
https://doi.org/10.1371/journal.pone.0205719.g003
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impaired fractional shortening [30], we investigated whether the mutated and healthy cardio-
myocytes respond differently to the following positive inotropic interventions: (1) β-adrener-
gic stimulation by isoproterenol; (2) elevated [Ca2+]out; (3) AT-II.
β-adrenergic stimulation. A fundamental cardiac feature is β-adrenergic positive inotro-
pic response caused by increased sarcoplasmic reticulum (SR) Ca2+ release through ryanodine
receptor 2 (RyR2) channels [31]. This effect is demonstrated in healthy cardiomyocytes by a
dose-dependent increase in [Ca2+]i transient amplitude, maximal rate of [Ca
2+]i rise and decay
of the [Ca2+]i transient, contraction amplitude and maximal rates of contraction and relaxa-
tion (representative traces in Fig 5A, black symbols in Fig 5D–5I). In contrast, the mutated car-
diomyocytes (representative traces in Fig 5B and Fig 5C for IsP and AuP, respectively) were
barely responsive to isoproterenol respecting all measured parameters (red and blue symbols
for IsP and AuP in Fig 5D–5I, respectively).
Elevated [Ca2+]out. To decipher whether the attenuated response to isoproterenol was
due to dysfunctional β-adrenergic cascade or alternatively–due to impaired downstream ele-
ment mediating any positive inotropic intervention, we investigated the inotropic effect of ele-
vating [Ca2+]out (2, 3, 4 and 5 mM), which augments L type Ca
2+ current (ICa,L), in turn
increasing SR Ca2+ release, thereby increasing contractile force [32]. As seen in Fig 6, while
control cardiomyocytes were responsive to elevated [Ca2+]out, that of mutated cardiomyocytes
Fig 4. The [Ca2+]i transient and contraction characteristics in healthy and mutated (IsP and AuP) iPSC-CM. [A] Simultaneous recording of [Ca
2+]i transient
(orange) and contraction (green) measured from healthy (left), IsP (middle) and AuP (right) iPSC-CM. [B-D] [Ca2+]i transient healthy (clone 24.5 n = 32), IsP (clone
23.2 n = 8, clone 23.10 n = 12 n = 20), (AuP n = 9) amplitude and maximal rates of [Ca2+]i rise and decay, respectively. [E-G] Contraction healthy (clone 24.5 n = 27),
IsP (clone 23.2 n = 16, clone 23.10 n = 19, n = 35), AuP (n = 14) amplitude and maximal rates of contraction and relaxation, respectively. Next to each column of
individual values, the Mean+SEM (filled symbol) is shown. One-way ANOVA was performed followed by Holm-Sidak test, �P<0.05, ��P<0.01 and ���P<0.001 vs.
healthy.
https://doi.org/10.1371/journal.pone.0205719.g004
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was blunted. Specifically, all contraction parameters of IsP and AuP iPSC-CM were signifi-
cantly lower than those of healthy iPSC-CM (Fig 6G–6I). In addition, there was no difference
in [Ca2+]i transient parameters between the 3 groups, except for maximal rate of [Ca
2+]i decay
which was significantly higher (than control) in IsP cardiomyocytes (Fig 6D–6F).
Angiotensin-II (AT-II). Based on the above mentioned findings we speculated that the
SR–the downstream common step mediating these positive inotropic effectors, is defective in
titin-mutated cardiomyocytes. To test this notion, we investigated whether AT-II, also induc-
ing its positive inotropy via SR-Ca2+ release [21], is equally ineffective in mutated cardiomyo-
cytes. Indeed, while in healthy iPSC-CM AT-II caused a prominent dose-dependent positive
inotropic and lusitropic effects, markedly augmenting both [Ca2+]i transient and contraction
characteristics (Fig 7), mutated cardiomyocytes were unresponsive, collectively suggesting that
a down-stream step mediating the positive inotropic and lusitropic effect is defected in the
titin-mutated cardiomyocytes.
Mechanisms underlying attenuated inotropic response of mutated
iPSC-CM
To determine possible mechanisms underlying the depressed inotropic response of mutated
iPSC-CM, we investigated: (1) structural features and sarcomeric organization; (2) The RyR-
mediated SR Ca2+ release using caffeine; (3) The proteomic profile using MS-based shotgun
proteomics.
Structural features and sarcomeric organization. To determine whether titin mutations
are associated with ultrastructural changes, the Z-width measurements and sarcomere length
analysis were performed on 30- and 60-day-old IsP (clones 23.2 and 23.10), AuP (clone T1)
and healthy (clones 24.5 and KTN3) EBs. The sarcomere length analysis showed no significant
differences between healthy and Aup and IsP cardiomyocytes, regardless of age (see Panels D
and E of FigD and FigE in S1 File and raw data in Table A in S1 File). iPSC-CM showed a het-
erogeneous cell morphology, round-oval cells connected with elongated and stellate cells. Also
iPSC-CM showed various amounts of primitive Z-dense bodies, nascent sarcomeres or primi-
tive sarcomeres forming myofibrils of variable length. Healthy and mutated iPSC-CM con-
tained myofibrils that showed poor alignment or organized sarcomeric pattern on all samples,
consistent with the immature phenotype. The number of sarcomeres could not be appreciated
with a degree of satisfactory accuracy because CM in EBs showed an irregular shape, with cel-
lular extensions not trapped in the 60 nm section plane. Very few myofibrils developed A- and
I-bands either at 30 days or 56 days post-plating from control and titin mutated EBs and this
aspect could not be reliable quantified on ultrathin sections.
Sarcomeric organization of mutated and healthy iPSC-CM was determined by co-staining
of α-actinin (Z disk) and cardiac troponin-T (A-band) [10]. Briefly, single cardiomyocytes
were dissociated from spontaneously beating embryoid bodies (EBs), and analyzed 7 days
later. Cardiomyocytes were divided into 3 groups according to sarcomeric organization
Fig 5. Effect of isoproterenol on contraction and [Ca2+]i transient parameters of healthy and mutated iPSC-CM. [A-C] Representative
contractions (LAmplitude) from healthy [A], IsP [B] and AuP [C] iPSC-CM in the absence and presence of isoproterenol. Panels [D-F] display the
summary of [Ca2+]i transient parameters of mutated (red–IsP, clone 23.2 n = 2, clone 23.10 n = 1, n = 3; blue–AuP, n = 8) and healthy (black–clone
24.5 n = 6) iPSC-CM: amplitude [D], and maximal rates of [Ca2+]i rise [E] and decay [F]. Panels [G-I] show the reduced response of mutated
iPSC-CM (red–IsP, clone 23.2 n = 6, clone 23.10 n = 2, n = 8; blue–AuP, n = 8) compared to healthy (black–clone 24.5 n = 6) iPSC-CM in all
contraction parameters: amplitude [G], and maximal rates of contraction [H] and relaxation [I]. Results are expressed as percent change from control
values in Tyrode’s solution. Two-way ANOVA was performed followed by Holm-Sidak test. Two-way ANOVA showed a statistically significant
difference in all 3 contraction parameters between healthy and IsP groups (P<0.05). Statistically significant difference was also seen in maximal rate
of [Ca2+]i rise and relaxation between the 2 groups. For specific isoproterenol concentrations:
�P<0.05, ��P<0.01, ���P<0.001 vs Healthy. ISO–
isoproterenol; Tyr–Tyrode’s solution.
https://doi.org/10.1371/journal.pone.0205719.g005
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extending to: (1) the whole cytoplasm (Fig 8A, upper row); (2) <50% of the whole cytoplasm
with main localization in the cell periphery (Fig 8A, middle row); (3) <50% of the whole cyto-
plasm with main localization in the perinuclear area (Fig 8A, lower row). As seen in Fig 8B, the
percentage of cells with fully structured myofilaments occupying the entire cytoplasm is signif-
icantly reduced in IsP compared to healthy iPSC-CM (44% vs. 80%, respectively, P<0.0001).
In contrast, in IsP iPSC-CM there is a higher percentage of cardiomyocytes in which organized
myofibrils occupy only half of the cytoplasm or even less (P<0.0001). This group was further
divided into two sub-groups according to the localization of the few organized myofibrils,
which were visible either in the perinuclear area or at the cell periphery (Fig 8B). In the IsP
group 26.6% of the cells show a sarcomere with an organized pattern visible only in the peri-
nuclear area and 29.4% display an organized pattern limited at the cell periphery. The respec-
tive percentages in the healthy iPSC-CM were 7.3% and 12.4%, respectively. Importantly, these
results are in agreement with the findings obtained by Gramlich et al in AuP cardiomyocytes
(fully organized 54%, perinuclear 17%, and peripherally 29%) [10], suggesting the presence of
titin mutation-related defects in both myofibril reassembly and sarcomere stability.
The RyR-mediated SR Ca2+ release using caffeine. To decipher the mechanism(s) underly-
ing the diminished response of titin-mutated iPSC-CM to all positive inotropic interventions
operating by increasing [Ca2+]i, we tested the effect of a brief application of caffeine (10 mM,
serves as an opener of the RyR2 receptor [12]) on the [Ca2+]i transient. As illustrated by the repre-
sentative experiments (Fig 9A–9C) and summary (Fig 9D and 9E), titin-mutated and healthy car-
diomyocytes differed in their response to caffeine. As we previously reported [12], healthy
iPSC-CM displayed an abrupt amplitude transient increase in intracellular Ca2+ concomitant
with contraction cessation, followed by a decline in the Ca2+ level along resumption of contrac-
tions after ~10 sec (Fig 9A). In contrast, mutated iPSC-CM displayed prolonged recovery which
was divided into two phases: (1) decline in [Ca2+]i level as seen in healthy cardiomyocytes, but not
to the basal level; (2) a gradual slow decline that lasts few minutes until reaching basal [Ca2+]i
level, during which resumption of contractions occurs (Fig 9B) (in IsP but not AuP cardiomyo-
cytes). Consequently, IsP iPSC-CM recovery following caffeine administration was much slower
compared to healthy iPSC-CM and the gradual decline in [Ca2+]i level was longer (Fig 9D).
Protein expression analysis. Altogether, 301 unique proteins showed significant expres-
sion changes between AuP and healthy cardiomyocytes (151 upregulated and 150 downregu-
lated; permutation-based FDR 0.05, S0 0.5) (Fig 10A). In the cluster of upregulated proteins,
the top 3 significantly enriched keyword categories were Extracellular matrix, Actin-binding
and Muscle protein, whereas Disease mutation, Calcium and Cardiomyopathy were identified
as top significantly enriched Keyword terms within the downregulated proteins (Fig 10B). An
additional detailed analysis of the proteome profile of the AuP cardiomyocytes revealed that
indeed the expression levels of three important cardiac Ca2+ handling proteins (the ryanodine
receptor 2—RYR2, the sarcoplasmic reticulum histidine-rich calcium-binding protein—HRC,
and the sodium/calcium exchanger 1—SLC8A1) were significantly reduced in patient cells
(Fig 10D).
Fig 6. Effect of increasing [Ca2+]out on contraction and [Ca
2+]i transient parameters of healthy and mutated iPSC-CM. [A-C] Representative
contractions (LAmplitude) from healthy [A], IsP [B] and AuP [C] iPSC-CM in presence of increased [Ca
2+]out. Panels [D-F] display the summary of
[Ca2+]i transient parameters of mutated (red–IsP, clone 23.2 n = 3, clone 23.10 n = 4, n = 7; blue–AuP, n = 8) and healthy (black–clone 24.5 n = 7)
iPSC-CM: amplitude [D], and maximal rates of [Ca2+]i rise [E] and decay [F]. Panels [G-I] show the reduced response of mutated iPSC-CM (red–IsP,
clone 23.2 n = 7, clone 23.10 n = 11, n = 18; blue–AuP, n = 11) compared to healthy (black–clone 24.5 n = 12) iPSC-CM in all contraction parameters:
amplitude [G], and maximal rates of contraction [H] and relaxation [I]. Results are expressed as percent change from control values at 2 mM. Two-
way ANOVA was performed followed by Holm-Sidak test. Two-way ANOVA showed a statistically significant difference in all 3 contraction
parameters between healthy and AuP groups and between healthy and IsP groups (P<0.05). Statistically significant difference was also seen in
maximal rate of [Ca2+]i relaxation between all 3 groups. For specific [Ca
2+]out concentrations:
�P<0.05 vs Healthy, ��P<0.01, ���P<0.001.
https://doi.org/10.1371/journal.pone.0205719.g006
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Discussion
To decipher the cellular mechanisms underlying the functional abnormalities, we investigated
the actual mutated cardiomyocytes derived from DCM patients carrying titin mutations. The
major findings were: (1) diminished response to isoproterenol, elevated [Ca2+]out and AT-II;
(2) altered response to caffeine, compared to healthy cardiomyocytes.
Fig 7. Effect of AT-II on contraction and [Ca2+]i transient parameters of healthy and mutated iPSC-CM. [A-C] Representative contractions
(LAmplitude) from healthy [A], IsP [B] and AuP [C] iPSC-CM in the absence and presence of AT-II. Panels [D-F] display the summary of [Ca
2+]i
transients parameters of mutated (red–IsP, clone 23.2 n = 2, clone 23.10 n = 8, n = 10; blue–AuP, n = 5) and healthy (black–clone 24.5 n = 8)
iPSC-CM: amplitude [D], and maximal rates of [Ca2+]i rise [E] and decay [F]. Panels [G-I] show the reduced response of mutated iPSC-CM (red–IsP
clone 23.2 n = 3, clone 23.10 n = 6, n = 9; AuP–blue, n = 5) compared to healthy (black–clone 24.5 n = 11) iPSC-CM in all contraction parameters:
amplitude [G], and maximal rates of contraction [H] and relaxation [I]. Results are expressed as percent change from control values in Tyrode’s
solution. Two-way ANOVA was performed followed by Holm-Sidak test. Two-way ANOVA showed a statistically significant difference in all 3
contraction parameters between healthy and IsP groups (P<0.001). Statistically significant difference was also seen in [Ca2+]i transient amplitude
between the 2 groups. For specific AT-II concentrations: ��P<0.01, ���P<0.001 vs Healthy. AT-II–angiotensin-II; Tyr–Tyrode’s solution.
https://doi.org/10.1371/journal.pone.0205719.g007
Fig 8. Levels of sarcomeric organization in control and IsP iPSC-CM. Panel [A] shows immunofluorescence images of α-actinin and cardiac troponin-T (cTNT) in
healthy and IsP mutated single cardiomyocytes, illustrating three different levels of sarcomeric organization—fully, peripherally and perinuclear organized (upper,
middle and lower panels, respectively). Panel [B] presents percentage of cells with different levels of sarcomeric organization. Statistic difference was tested using the chi-
squared test Healthy (clone 24.5 n = 274), IsP (clone 23.2 n = 160, clone 23.10 n = 160, n = 320; ����P<0.001 Healthy vs IsP iPSC-CM). Scale bars = 25 μm.
https://doi.org/10.1371/journal.pone.0205719.g008
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Spontaneous electrophysiological features of titin-mutated iPSC-CM
Despite the statistically significant lower firing rate of IsP iPSC-CM and prolonged APD displayed
by both IsP and AuP iPSC-CM, these differences lack practical significance since the mean firing
rate and APD values fall well within the normal range previously described in iPSC-CM [29,33].
Additionally, when corrected to beat rate, the only significant difference in APD90 was between
IsP iPSC-CM and control. Furthermore, this difference was less than 40 ms, leaving IsP iPSC-CM
well within the normal range and thus lacking practical significance [33].
AuP iPSC-CM exhibited markedly increased BRV indices compared to healthy and IsP
iPSC-CM. The mutation in both IsP and AuP patients deletes the A-band segment, leading to
defective sarcomerogenesis through disruption of mechanical force transmission from myosin
[34]. Currently, we do not know the reason for this difference in BRV parameters. Perhaps it is
associated with disturbed mitochondrial Ca2+ handling machinery, which we previously
showed to affect BRV magnitude [11].
Attenuated responsiveness of mutated iPSC-CM to isoproterenol and
[Ca2+]out
While the basal [Ca2+]i transient and contraction parameters were mostly similar, the positive
inotropic response of the mutated cardiomyocytes was markedly suppressed. While healthy
cardiomyocytes exhibited the expected positive inotropic and lusitropic effects, the mutated
cardiomyocytes displayed blunted response to isoproterenol (Fig 3). These findings are in
agreement with 2 recent studies: (1) Hinson and co-workers showed that iPSC-CM generated
from DCM patient carrying the pP22582fs+/- titin mutation (different than the AuP and IsP
mutations) demonstrated diminished responses to β-adrenergic stress using contractile func-
tion assay [35]. (2) Peng et al reported diminished response to increased [Ca2+]out and isopro-
terenol of cardiomyocytes derived from titin M-line deficient mice, which was attributed to
reduction in expression levels of Ca2+ handling proteins SERCA2 and PLB [36]. In addition,
reduction in protein expression levels was observed also for the Ca2+-binding protein calmod-
ulin, which participates in SR Ca2+release and regulates the activity of SERCA2 and PLB
through Ca2+/Calmodulin-dependent kinase II (CaMKII) [36]. Further details regarding the
titin kinase domain are provided below.
Next, we subjected the healthy and mutated cardiomyocytes to increased [Ca2+]out. Positive
inotropic and lusitropic effects in all 3 contraction parameters–amplitude, maximal rates of
contraction and relaxation—were observed in healthy cardiomyocytes, as previously reported
[32,36] (Fig 6). Nevertheless, IsP and AuP cardiomyocytes displayed reduced response to
increased [Ca2+]out compared to healthy cells. In contrast, only the maximal rate of [Ca
2+]i
relaxation differed between the three groups.
Impaired responsiveness of mutated iPSC-CM to AT-II and caffeine
Subsequent to the findings of decreased response of titin-mutated iPSC-CM to isoproterenol
and [Ca2+]out, we sought to decipher the contribution of the SR to these findings. Therefore we
Fig 9. Effect of caffeine on [Ca2+]i cycling of healthy and mutated iPSC-CM. Representative [Ca
2+]i transients from healthy [A], IsP [B] and AuP [C]
iPSC-CM under caffeine administration (indicated by red arrow). The IsP cardiomyocytes display two-phase decline in [Ca2+]i level: fast decline as in
healthy cells, and gradual slow decline until reaching [Ca2+]i basal level [B]. [D] Average recovery time from maximum of caffeine peak phase until the
beginning of departing phase of the first measurable [Ca2+]i transient post-caffeine insertion of healthy (24.5 clone n = 11), IsP (clone 23.2 n = 2, clone 23.10
n = 4, n = 6) and AuP (n = 8) iPSC-CM. [E] display the percent change in fold change in area of caffeine-induced [Ca2+]i signal compared to the pre-caffeine
[Ca2+]i transient of healthy (clone 24.5 n = 11), IsP (clone 23.2 n = 2, clone 23.10 n = 4, n = 6) and AuP (n = 8) iPSC-CM. One-way ANOVA was performed
followed by Holm-Sidak test, ���P< 0.001 (vs Control and AuP).
https://doi.org/10.1371/journal.pone.0205719.g009
Functional abnormalities in iPSC-CMs generated from titin-mutated patients with dilated cardiomyopathy
PLOS ONE | https://doi.org/10.1371/journal.pone.0205719 October 17, 2018 18 / 25
Functional abnormalities in iPSC-CMs generated from titin-mutated patients with dilated cardiomyopathy
PLOS ONE | https://doi.org/10.1371/journal.pone.0205719 October 17, 2018 19 / 25
investigated in healthy and mutated iPSC-CM the effect of AT-II, promoting synthesis of
1,4,5-inositol triphosphate (1,4,5-IP3) which triggers SR Ca
2+ release [21]. Similarly to isoproter-
enol and [Ca2+]out, AT-II caused positive inotropic and lusitropic effects in healthy iPSC-CM
on [Ca2+]i transient and contraction parameters, as opposed to lack of response in IsP and AuP
iPSC-CM (Fig 7). These results are consistent with results published by Gramlich et al [30]. The
authors found that mice with truncated titin lacking part of the A-band and the M-band regions
showed no alterations in cardiac morphology and function under normal conditions. However,
when exposed to cardiac stress by means of isoproterenol or AT-II, these agents mimicked typi-
cal features of DCM—left ventricular dilatation with impaired fractional shortening.
To further investigate intracellular Ca2+ handling, we studied the effect of a brief application
of caffeine (10 mM). Caffeine, being an opener of the RyR2 receptor, induces Ca2+ release
from the SR which results in increased [Ca2+]i levels [12]. IsP iPSC-CM showed longer recov-
ery period until resumption of contraction compared to healthy and AuP iPSC-CM (Fig 9).
Moreover, when compared to healthy cells, diastolic Ca2+ remained elevated in patient
iPSC-CM after caffeine application, suggesting defects in SR calcium re-uptake and/or cellular
Ca2+ efflux. Concordantly, proteomic analysis in AuP iPSC-CM revealed reduced level of the
sarcoplasmic reticulum histidine-rich calcium-binding protein (HRC), a regulator of Ca2+
sequestration in the SR [37], and the sodium/calcium exchanger (SLC8A1), which represents
the major Ca2+ efflux mechanism in cardiac myocytes (Fig 10D) [37]. Similar results were
reported for cardiomyocytes derived from patients in a DCM family carrying a point mutation
in cardiac troponin-T gene [38]. These cardiomyocytes displayed prolonged decay time in
response to caffeine, suggesting altered function of Ca2+ pumps in the sarcolemma and SR
membranes. Furthermore, DCM iPSC-CM displayed abnormal contractility which was res-
cued following overexpression of SERCA2, indicating compromised Ca2+ handling in DCM
cardiomyocytes due to reduced expression of SERCA2 and other Ca2+ related elements
[36,38]. In addition, we showed that in response to caffeine administration iPSC-CM gener-
ated from catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2) patients
exhibited two-phase decline in Ca2+ level compared to healthy cells [12]. We suggested that
the vast and prolonged Ca2+ release is due to the mutated calsequestrin protein in the CPVT2
patients which result in high levels of free Ca2+ in the SR, and not necessarily from a total
higher SR Ca2+ levels [12]. Accordingly, altered function of Ca2+ handling protein such as cal-
sequestrin and SERCA2 might be the reason for the abnormal response of IsP iPSC-CM in
response to caffeine. This aspect is further detailed below.
Structural analysis in titin-mutated cardiomyocytes
TEM analysis showed that both healthy and mutated iPSC-CM had nascent sarcomeres and
disarrayed myofibrils with clear Z bands, with no ultrastructural differences between the three
cell types in both age groups. Several studies reported on immature sarcomere and myofibrils
structure in healthy cardiomyocytes seen in long-term culture up to 180 days [20,39]. More-
over, only in 360 day-old cardiomyocytes there were first signs of M-band [39]. An important
study by Hinson et al demonstrated shorter sarcomere length in titin-truncated iPSC-CM
Fig 10. Mass spectrometry-based proteomic analysis of AuP and healthy cardiomyocytes. [A] Unsupervised hierarchical clustering of 301 proteins with
significantly different expression in healthy (clone 24.5) and AuP cardiomyocytes (FDR 0.05, S0 0.5). Technical triplicates are shown for each sample. Healthy 1
and 2 indicate two unrelated control individuals. [B] Bar graphs showing the fold increase of the top three annotation enrichments in the cluster of proteins that
are upregulated (red bars) and downregulated (green bars) in the AuP cardiomyocytes. The corresponding p value is reported next to each bar. [C] Volcano plot
of statistical significance against fold-change (FDR 0.05, S0 0.5), highlighting the proteins with higher expression in control (black) and AuP (blue), respectively.
[D] Bar plots depicting the log2 fold change expression of selected cardiac Ca2+ handling proteins that are differentially expressed between AuP and both healthy
control cardiomyocytes.
https://doi.org/10.1371/journal.pone.0205719.g010
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compared to wild-type, but the authors used three-dimensional cardiomyocytes microtissues
that can be possibly more mature than our cultured iPSC-CM [35]. Perhaps immaturity of the
iPSC-CM is the reason for the presence of only clear Z bands in titin-mutated and healthy 31-
and 56-day-old cardiomyocytes. Sarcomeric organization analysis showed defects in assembly
and maintenance of a stable sarcomeric structure in mutated IsP compared with healthy
iPSC-CM (Fig 8), which corresponds to the results of Gramlich et al in AuP iPSC-CM [10].
We performed sarcomeric organization analysis and found defects in assembly and mainte-
nance of a stable sarcomeric structure in titin-mutated IsP iPSC-CM which lack the A-band
segment. These results corresponds to those of Gramlich et al in AuP iPSC-CM which also
lack the A-band segment [10]. In addition, Chopra et al found in titin-mutated iPSC-CM lack-
ing A-band segment generated from DCM patients, that titin truncation mutations lead to
defective sarcomere formation and myofibrillar assembly due to insufficient length of the titin
protein [34]. Furthermore, Tonino et al showed in a mouse model in which part of the A-band
was deleted that thick filament length was decreased in cardiac and skeletal muscles, and func-
tional studies revealed reduced force generation and a DCM phenotype [40]. These findings
suggest that titin truncation mutations leading to deletion of the A-band damage sarcomero-
genesis through disruption of mechanical force transmission from myosin [34].
Titin kinase domain
The titin protein is located within the sarcomere as a third filament connecting between Z-line
and M-line. Between these edges, the titin is divided between the A-band and the elastic and
extensible I-band. We performed sarcomeric organization analysis and found defects in
assembly and maintenance of a stable sarcomeric structure in titin-mutated IsP iPSC-CM
which lack the A-band segment. These results correspond to those of Gramlich et al in AuP
iPSC-CM which also lack the A-band segment. In addition, Chopra et al found in titin-
mutated iPSC-CM lacking A-band segment generated from DCM patients, that titin trunca-
tion mutations lead to defective sarcomere formation and myofibrillar assembly due to insuffi-
cient length of the titin protein. Furthermore, Tonino et al showed in a mouse model in which
part of the A-band was deleted that thick filament length was decreased in cardiac and skeletal
muscles, and functional studies revealed reduced force generation and a DCM phenotype.
These findings suggest that titin truncation mutations leading to deletion of the A-band dam-
age sarcomerogenesis through disruption of mechanical force transmission from myosin.
In addition to its structural role, titin participates in various signal-transduction pathways
through several sites, specifically the titin kinase (TK) domain located at the M-band [41,42].
Several studies investigated TK and its diverse signaling pathways and interactions, and found
that it is involved in muscle mechanical signaling [42–45]. An important study by Peng et al
investigated the effect of TK absence on cardiac function using M-line deficient mice lacking
TK [36]. On the cellular level, there was no difference in sarcomere structure between 30-day
old control and M-line deficient cardiomyocytes, similar to our results obtained from ultra-
structure analysis. Only after 80 days in culture, M-line deficient cardiomyocytes displayed sar-
comere disassembly. Additionally, cardiac function was investigated, and under basal
conditions there was no difference between 30-day old control and M-line deficient cardio-
myocytes, similar to our findings of contraction parameters. Moreover, the β-adrenergic stim-
ulator dobutamine which causes a positive inotropic effect, caused blunted response in M-line
deficient cardiomyocytes compared to control, in agreement with our findings in titin-
mutated cardiomyocytes [36]. The authors suggested that the mechanism underlying the
reduced contractility of M-line deficient cardiomyocytes, is associated with calcium handling
machinery, and is based on protein expression levels analysis in which early reduction of
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SERCA2 and PLB levels was observed. These results may indicate that titin serves as a contrac-
tility regulator through its TK effects on calcium handling proteins [36].
The above mentioned findings indicate TK importance in myofibrillar mechanical signal-
ing, contractile function and cardiac gene expression. These findings may constitute the basis
for the results obtained from IsP and AuP titin-mutated cardiomyocytes, which lack the M-
line region and specifically the TK domain. Furthermore, our results are consistent with results
previously published by Gramlich and co-workers [30]. This group found that mice with trun-
cated titin lacking the TK show no alterations in cardiac morphology and function under nor-
mal conditions. However, when exposed to cardiac stress by means of isoproterenol or AT-II,
they mimic typical features of DCM—left ventricular dilatation with impaired fractional short-
ening. More importantly, Gramlich et al (2015) generated iPSC-CM from Australian DCM
patient (AuP) which lack the TK domain due to titin truncation mutation in exon 327 [10].
Significant down regulation of α- and β- myosin heavy chain and cardiac α-actin was observed
in mutated cells compared with control, similar to previously published results [10,45].
These findings strengthen the notion that titin plays a key role in various cellular pathways,
in addition to its role as molecular spring. Specifically, the TK domain is crucial for sarcomere
assembly and stability, mechanosensory processes and regulation of gene expression through
interactions with diverse proteins. Truncation of TK domain in mutant iPSC-CM may be a
plausible mechanistic link to explain the observed results; however, this hypothesis was not
addressed in the present study.
Altogether, we investigated iPSC-CMs from an Israeli (IsP) and Australian (AuP) titin-
mutated (carrying different mutations) patients. All the findings on the IsP iPSC-CM are new.
A recent study [10] by Moretti, Gramlich (co-authors on this manuscript) and co-workers
using AuP iPSC-CM demonstrated that: (1) Correction of TTN reading frame in patient-spe-
cific cardiomyocytes derived from induced pluripotent stem cells rescued defective myofibril
assembly and stability and normalized the sarcomeric protein expression (2) AON treatment in
TTN knock-in mice improved sarcomere formation and contractile performance in homozy-
gous embryos and prevented the development of the DCM phenotype in heterozygous animals.
(3) Disruption of the TTN reading frame due to a truncating DCM mutation can be restored by
exon skipping in both patient cardiomyocytes in vitro and mouse heart in vivo, indicating
RNA-based strategies as a potential treatment option for DCM. All other findings regarding
action potential characteristics, beat rate variability, ultrastructural analysis, inotropic respon-
siveness to AT-II and [Ca 2+]out, response to caffeine and proteomics, are completely novel.
In summary, our findings reflect an underlying abnormal contraction and calcium han-
dling mechanism, which can be attributed to lack of titin kinase domain in the DCM patients.
The kinase domain is involved in regulation of cardiac gene expression through interactions
with MURF proteins, as was reported by several studies [36,43–45], and this involvement
might contribute to the reduced response of titin-mutated iPSC-CM to positive inotropic
interventions. Additional research is required to decipher the specific mechanism(s) responsi-
ble for the reduced contractility of IsP and AuP titin-mutated cardiomyocytes.
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